Clinical trial

Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia

NCT01043458

Study summary

ClinicalTrials.gov

Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

StatusCOMPLETED
Study typeINTERVENTIONAL
Start date2009-11-01
PhasePHASE1
Advertisement

Sponsors & collaborators

Abbottlead sponsor

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.